AAAAAA

   
Results: 1-25 | 26-50 | 51-51
Results: 26-50/51
GASTRIC-EMPTYING GLUCOSE RESPONSES, AND INSULIN-SECRETION AFTER A LIQUID TEST MEAL - EFFECTS OF EXOGENOUS GLUCAGON-LIKE PEPTIDE-1 (GLP-1)-(7-36) AMIDE IN TYPE-2 (NONINSULIN-DEPENDENT) DIABETIC-PATIENTS
Authors: WILLMS B WERNER J HOLST JJ ORSKOV C CREUTZFELDT W NAUCK MA
Citation: B. Willms et al., GASTRIC-EMPTYING GLUCOSE RESPONSES, AND INSULIN-SECRETION AFTER A LIQUID TEST MEAL - EFFECTS OF EXOGENOUS GLUCAGON-LIKE PEPTIDE-1 (GLP-1)-(7-36) AMIDE IN TYPE-2 (NONINSULIN-DEPENDENT) DIABETIC-PATIENTS, The Journal of clinical endocrinology and metabolism, 81(1), 1996, pp. 327-332
ERYTHROMYCIN, BUT NOT METOCLOPRAMIDE, DOMPERIDONE, OR CISAPRIDE ANTAGONIZE THE INHIBITION OF GASTRIC-EMPTYING BY GLP-1 IN HEALTHY-VOLUNTEERS
Authors: NAUCK MA GROSSER S KEMMERIES G ORSKOV C HOLST JJ SCHMIEGEL W
Citation: Ma. Nauck et al., ERYTHROMYCIN, BUT NOT METOCLOPRAMIDE, DOMPERIDONE, OR CISAPRIDE ANTAGONIZE THE INHIBITION OF GASTRIC-EMPTYING BY GLP-1 IN HEALTHY-VOLUNTEERS, Gastroenterology, 110(4), 1996, pp. 723-723
EVIDENCE AGAINST A PHYSIOLOGICAL-ROLE OF GLP-1 AS AN INSULINOTROPIC INCRETIN HORMONE IN HEALTHY-VOLUNTEERS
Authors: NAUCK MA NIEDEREICHHOLZ U ETTLER R ORSKOV C HOLST JJ SCHMIEGEL W
Citation: Ma. Nauck et al., EVIDENCE AGAINST A PHYSIOLOGICAL-ROLE OF GLP-1 AS AN INSULINOTROPIC INCRETIN HORMONE IN HEALTHY-VOLUNTEERS, Gastroenterology, 110(4), 1996, pp. 1103-1103
DETERMINANTS OF A NORMAL (VERSUS IMPAIRED) ORAL GLUCOSE-TOLERANCE AFTER COMBINED PANCREAS-KIDNEY TRANSPLANTATION IN IDDM PATIENTS
Authors: PFEFFER F NAUCK MA BENZ S GWODZINSKI A ZINK R BUSING M BECKER HD HOPT UT
Citation: F. Pfeffer et al., DETERMINANTS OF A NORMAL (VERSUS IMPAIRED) ORAL GLUCOSE-TOLERANCE AFTER COMBINED PANCREAS-KIDNEY TRANSPLANTATION IN IDDM PATIENTS, Diabetologia, 39(4), 1996, pp. 462-468
EFFECTS OF SUBCUTANEOUS GLUCAGON-LIKE PEPTIDE-1 (GLP-1 [7-36 AMIDE]) IN PATIENTS WITH NIDDM
Authors: NAUCK MA WOLLSCHLAGER D WERNER J HOLST JJ ORSKOV C CREUTZFELDT W WILLMS B
Citation: Ma. Nauck et al., EFFECTS OF SUBCUTANEOUS GLUCAGON-LIKE PEPTIDE-1 (GLP-1 [7-36 AMIDE]) IN PATIENTS WITH NIDDM, Diabetologia, 39(12), 1996, pp. 1546-1553
A LIQUID MIXED MEAL OR EXOGENOUS GLP-1 DO NOT ALTER PLASMA LEPTIN CONCENTRATIONS IN HEALTHY-VOLUNTEERS
Authors: DREWES C NAUCK MA HORN R NIEDEREICHHOLZ U ETTLER R HOLST J SCHMIEGEL W BRABANT G
Citation: C. Drewes et al., A LIQUID MIXED MEAL OR EXOGENOUS GLP-1 DO NOT ALTER PLASMA LEPTIN CONCENTRATIONS IN HEALTHY-VOLUNTEERS, Diabetologia, 39, 1996, pp. 540-540
FAILURE TO LOWER 24H-GLUCOSE PROFILES THROUGH NORMALIZING FASTING VALUES BY OVERNIGHT INFUSIONS OF GLP-1 IN NIDDM
Authors: WILLMS B IDOWU K HOLST JJ NAUCK MA
Citation: B. Willms et al., FAILURE TO LOWER 24H-GLUCOSE PROFILES THROUGH NORMALIZING FASTING VALUES BY OVERNIGHT INFUSIONS OF GLP-1 IN NIDDM, Diabetologia, 39, 1996, pp. 590-590
ERYTHROMYCIN ANTAGONIZES THE INHIBITION OF GASTRIC-EMPTYING BY GLP-1 AND UNMASKS IT POSTPRANDIAL INSULINOTROPIC ACROSS
Authors: NAUCK MA GROSSER S KEMMERIES G ORSKOV C HOLST JJ SCHMIEGEL W
Citation: Ma. Nauck et al., ERYTHROMYCIN ANTAGONIZES THE INHIBITION OF GASTRIC-EMPTYING BY GLP-1 AND UNMASKS IT POSTPRANDIAL INSULINOTROPIC ACROSS, Diabetologia, 39, 1996, pp. 591-591
OVERNIGHT GLP-1 [7-36 AMIDE], DAYTIME ORAL-AGENTS - FAILURE TO LOWER POSTPRANDIAL GLUCOSE BY NORMALIZING FASTING VALUES IN NIDDM PATIENTS
Authors: WILLMS B IDOWU K HOLST JJ NAUCK MA
Citation: B. Willms et al., OVERNIGHT GLP-1 [7-36 AMIDE], DAYTIME ORAL-AGENTS - FAILURE TO LOWER POSTPRANDIAL GLUCOSE BY NORMALIZING FASTING VALUES IN NIDDM PATIENTS, Diabetes, 45, 1996, pp. 1119-1119
INSULINOTROPIC ACTIONS OF INTRAVENOUS GLUCAGON-LIKE PEPTIDE-1 (GLP-1)[7-36-AMIDE] IN THE FASTING STATE IN HEALTHY-SUBJECTS
Authors: QUALMANN C NAUCK MA HOLST JJ ORSKOV C CREUTZFELDT W
Citation: C. Qualmann et al., INSULINOTROPIC ACTIONS OF INTRAVENOUS GLUCAGON-LIKE PEPTIDE-1 (GLP-1)[7-36-AMIDE] IN THE FASTING STATE IN HEALTHY-SUBJECTS, Acta diabetologica, 32(1), 1995, pp. 13-16
PHYSIOLOGICAL AUGMENTATION OF AMINO ACID-INDUCED INSULIN-SECRETION BYGIP AND GLP-I BUT NOT BY CCK-8
Authors: FIESELER P BRIDENBAUGH S NUSTEDE R MARTELL J ORSKOV C HOLST JJ NAUCK MA
Citation: P. Fieseler et al., PHYSIOLOGICAL AUGMENTATION OF AMINO ACID-INDUCED INSULIN-SECRETION BYGIP AND GLP-I BUT NOT BY CCK-8, American journal of physiology: endocrinology and metabolism, 31(5), 1995, pp. 949-955
GLUCAGON-LIKE PEPTIDE-1 (7-36-AMIDE) SECRETION IN RESPONSE TO LUMINALSUCROSE FROM THE UPPER AND LOWER GUT - A STUDY USING ALPHA-GLUCOSIDASE INHIBITION (ACARBOSE)
Authors: QUALMANN C NAUCK MA HOLST JJ ORSKOV C CREUTZFELDT W
Citation: C. Qualmann et al., GLUCAGON-LIKE PEPTIDE-1 (7-36-AMIDE) SECRETION IN RESPONSE TO LUMINALSUCROSE FROM THE UPPER AND LOWER GUT - A STUDY USING ALPHA-GLUCOSIDASE INHIBITION (ACARBOSE), Scandinavian journal of gastroenterology, 30(9), 1995, pp. 892-896
PHARMACOKINETIC, INSULINOTROPIC, AND GLUCAGONOSTATIC PROPERTIES OF GLP-1 [7-36-AMIDE] AFTER SUBCUTANEOUS INJECTION IN HEALTHY-VOLUNTEERS - DOSE-RESPONSE-RELATIONSHIPS
Authors: RITZEL R ORSKOV C HOLST JJ NAUCK MA
Citation: R. Ritzel et al., PHARMACOKINETIC, INSULINOTROPIC, AND GLUCAGONOSTATIC PROPERTIES OF GLP-1 [7-36-AMIDE] AFTER SUBCUTANEOUS INJECTION IN HEALTHY-VOLUNTEERS - DOSE-RESPONSE-RELATIONSHIPS, Diabetologia, 38(6), 1995, pp. 720-725
EFFECTS OF SUBCUTANEOUS GLUCAGON-LIKE PEPTIDE-1 (GLP-1[7-36 AMIDE]) IN PATIENTS WITH TYPE-2-DIABETES
Authors: NAUCK MA WOLLSCHLAGER D WERNER J HOLST JJ ORSKOV C CREUTZFELDT W WILLMS B
Citation: Ma. Nauck et al., EFFECTS OF SUBCUTANEOUS GLUCAGON-LIKE PEPTIDE-1 (GLP-1[7-36 AMIDE]) IN PATIENTS WITH TYPE-2-DIABETES, Diabetologia, 38, 1995, pp. 39-39
DETERMINANTS OF A NORMAL ORAL GLUCOSE-TOLERANCE AFTER COMBINED PANCREAS-KIDNEY-TRANSPLANTATION
Authors: PFEFFER F NAUCK MA BENZ S GWODZINSKI A ZINK R BUSING M BECKER HD HOPT UT
Citation: F. Pfeffer et al., DETERMINANTS OF A NORMAL ORAL GLUCOSE-TOLERANCE AFTER COMBINED PANCREAS-KIDNEY-TRANSPLANTATION, Diabetologia, 38, 1995, pp. 83-83
PROLONGED NORMALIZATION OF FASTING GLYCEMIA BY INTRAVENOUS GLP-1 (]7-36 AMIDE] OR [7-37]) IN TYPE-2 DIABETIC-PATIENTS
Authors: WEBER I BACHESSER AK BACH I RICHTER S ORSKOV C HOLST JJ SCHMIEGEL W NAUCK MA
Citation: I. Weber et al., PROLONGED NORMALIZATION OF FASTING GLYCEMIA BY INTRAVENOUS GLP-1 (]7-36 AMIDE] OR [7-37]) IN TYPE-2 DIABETIC-PATIENTS, Diabetologia, 38, 1995, pp. 171-171
BOTH SUBCUTANEOUSLY AND INTRAVENOUSLY ADMINISTERED GLUCAGON-LIKE PEPTIDE-I ARE RAPIDLY DEGRADED FROM THE NH2-TERMINUS IN TYPE-II DIABETIC-PATIENTS AND IN HEALTHY-SUBJECTS
Authors: DEACON CF NAUCK MA TOFTNIELSEN M PRIDAL L WILLMS B HOLST JJ
Citation: Cf. Deacon et al., BOTH SUBCUTANEOUSLY AND INTRAVENOUSLY ADMINISTERED GLUCAGON-LIKE PEPTIDE-I ARE RAPIDLY DEGRADED FROM THE NH2-TERMINUS IN TYPE-II DIABETIC-PATIENTS AND IN HEALTHY-SUBJECTS, Diabetes, 44(9), 1995, pp. 1126-1131
NEW MOLECULAR BIOLOGICAL DISEASE MECHANIS MS FOR FORMATION OF HEREDITARY, NON-POLYPOSIS-ASSOCIATED COLORECTAL-CANCER - COMMENT
Authors: NAUCK MA HAHN SA SCHMIEGEL WH
Citation: Ma. Nauck et al., NEW MOLECULAR BIOLOGICAL DISEASE MECHANIS MS FOR FORMATION OF HEREDITARY, NON-POLYPOSIS-ASSOCIATED COLORECTAL-CANCER - COMMENT, Zeitschrift fur Gastroenterologie, 32(6), 1994, pp. 363-364
PHARMACOKINETIC, INSULINOTROPIC, AND GLUCAGONOSTATIC PROPERTIES OF GLP-1-[7-36 AMIDE] AFTER SC INJECTION IN HEALTHY-VOLUNTEERS
Authors: RITZEL R ORSKOV C HOLST JJ NAUCK MA
Citation: R. Ritzel et al., PHARMACOKINETIC, INSULINOTROPIC, AND GLUCAGONOSTATIC PROPERTIES OF GLP-1-[7-36 AMIDE] AFTER SC INJECTION IN HEALTHY-VOLUNTEERS, Diabetologia, 37, 1994, pp. 10000072-10000072
PRESERVED INCRETIN EFFECT IN TYPE-1 DIABETIC-PATIENTS WITH END-STAGE NEPHROPATHY TREATED BY COMBINED HETEROTOPIC PANCREAS AND KIDNEY-TRANSPLANTATION
Authors: NAUCK MA BUSING M ORSKOV C SIEGEL EG TALARTSCHIK J BAARTZ A BAARTZ T HOPT UT BECKER HD CREUTZFELDT W
Citation: Ma. Nauck et al., PRESERVED INCRETIN EFFECT IN TYPE-1 DIABETIC-PATIENTS WITH END-STAGE NEPHROPATHY TREATED BY COMBINED HETEROTOPIC PANCREAS AND KIDNEY-TRANSPLANTATION, Acta diabetologica, 30(1), 1993, pp. 39-45
NORMALIZATION OF FASTING HYPERGLYCEMIA BY EXOGENOUS GLUCAGON-LIKE PEPTIDE 1(7-36)AMIDE IN TYPE-2 (NON-INSULIN-DEPENDENT) DIABETIC-PATIENTS
Authors: NAUCK MA KLEINE N ORSKOV C HOLST JJ WILLMS B CREUTZFELDT W
Citation: Ma. Nauck et al., NORMALIZATION OF FASTING HYPERGLYCEMIA BY EXOGENOUS GLUCAGON-LIKE PEPTIDE 1(7-36)AMIDE IN TYPE-2 (NON-INSULIN-DEPENDENT) DIABETIC-PATIENTS, Digestion, 54(6), 1993, pp. 389-389
NORMALIZATION OF FASTING HYPERGLYCEMIA BY EXOGENOUS GLUCAGON-LIKE PEPTIDE-1 (7-36 AMIDE) IN TYPE-2 (NON-INSULIN-DEPENDENT) DIABETIC-PATIENTS
Authors: NAUCK MA KLEINE N ORSKOV C HOLST JJ WILLMS B CREUTZFELDT W
Citation: Ma. Nauck et al., NORMALIZATION OF FASTING HYPERGLYCEMIA BY EXOGENOUS GLUCAGON-LIKE PEPTIDE-1 (7-36 AMIDE) IN TYPE-2 (NON-INSULIN-DEPENDENT) DIABETIC-PATIENTS, Diabetologia, 36(8), 1993, pp. 741-744
NORMALIZATION OF FASTING HYPERGLYCEMIA BY EXOGENOUS GLP-1 (7-36 AMIDE) IN TYPE-2-DIABETIC
Authors: WILLMS B KLEINE N ORSKOV C HOLST JJ NAUCK MA CREUTZFELDT W
Citation: B. Willms et al., NORMALIZATION OF FASTING HYPERGLYCEMIA BY EXOGENOUS GLP-1 (7-36 AMIDE) IN TYPE-2-DIABETIC, Diabetologia, 36, 1993, pp. 10000047-10000047
INSULINOTROPIC ACTIONS OF GIP AND GLP-1 (7-36 AMIDE), BUT NOT OF CCK-8 AT PHYSIOLOGICALLY ELEVATED AMINO-ACID-CONCENTRATIONS
Authors: NAUCK MA FIESELER P ORSKOV C HOLST JJ NUSTEDE R MARTELL J
Citation: Ma. Nauck et al., INSULINOTROPIC ACTIONS OF GIP AND GLP-1 (7-36 AMIDE), BUT NOT OF CCK-8 AT PHYSIOLOGICALLY ELEVATED AMINO-ACID-CONCENTRATIONS, Diabetologia, 36, 1993, pp. 10000048-10000048
COMPARISON OF HYPERINSULINEMIC CLAMP EXPERIMENTS USING VENOUS, ARTERIALIZED VENOUS OR CAPILLARY EUGLYCEMIA
Authors: BLIETZ R QUALMANN C NAUCK MA
Citation: R. Blietz et al., COMPARISON OF HYPERINSULINEMIC CLAMP EXPERIMENTS USING VENOUS, ARTERIALIZED VENOUS OR CAPILLARY EUGLYCEMIA, Diabetologia, 36, 1993, pp. 10000130-10000130
Risultati: 1-25 | 26-50 | 51-51